These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 19616666)

  • 21. The paradoxical use of cardiac catheterization in patients with non-ST-elevation acute coronary syndromes: lessons from the Can Rapid Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the ACC /AHA Guidelines (CRUSADE) Quality Improvement Initiative.
    Cohen MG; Filby SJ; Roe MT; Chen AY; Menon V; Stouffer GA; Gibler WB; Smith SC; Pollack CV; Peterson ED; Ohman EM
    Am Heart J; 2009 Aug; 158(2):263-70. PubMed ID: 19619704
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aggressive statin therapy in multicenter and effectiveness for the reduction of intra-myocardial damage caused by non-ST elevation acute coronary syndrome: AMERICA study.
    Hara H; Nakamura M; Yokouchi I; Kimura K; Nemoto N; Ito S; Ono T; Itaya H; Shiba M; Wada M; Iijima R; Yamamoto M; Yamamoto M; Hara H; Takagi T; Asahara T; Mitsuo K; Kobayashi N; Sugi K
    Ther Adv Cardiovasc Dis; 2009 Oct; 3(5):357-65. PubMed ID: 19638365
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence and clinical impact of stroke complicating percutaneous coronary intervention: results of the Euro heart survey percutaneous coronary interventions registry.
    Werner N; Bauer T; Hochadel M; Zahn R; Weidinger F; Marco J; Hamm C; Gitt AK; Zeymer U
    Circ Cardiovasc Interv; 2013 Aug; 6(4):362-9. PubMed ID: 23899872
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence of in-hospital mortality or nonfatal myocardial infarction or nonfatal stroke in 216 diabetics and 552 nondiabetics undergoing percutaneous coronary intervention with stenting.
    Gamble SM; Saulle LN; Aronow WS; Alappat RM; Kalapatapu K; Pucillo AL; Monsen CE; Weiss MB
    Am J Ther; 2007; 14(5):435-7. PubMed ID: 17890930
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anemia, hemorrhage, and transfusion in percutaneous coronary intervention, acute coronary syndromes, and ST-segment elevation myocardial infarction.
    Willis P; Voeltz MD
    Am J Cardiol; 2009 Sep; 104(5 Suppl):34C-8C. PubMed ID: 19695359
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The region of Karlovac in the urgent PCI network].
    Horvat D; Grman J
    Acta Med Croatica; 2009 Feb; 63(1):99-101. PubMed ID: 19681472
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Value of blood transfusion in patients with a blood hematocrit of 24% to 30% after percutaneous coronary intervention.
    Maluenda G; Lemesle G; Ben-Dor I; Collins SD; Syed AI; Li Y; Torguson R; Kaneshige K; Xue Z; Suddath WO; Satler LF; Kent KM; Lindsay J; Pichard AD; Waksman R
    Am J Cardiol; 2009 Oct; 104(8):1069-73. PubMed ID: 19801026
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Time of onset and outcome of cardiogenic shock in acute coronary syndromes.
    Valente S; Lazzeri C; Chiostri M; Sori A; Giglioli C; Salvadori C; Gensini GF
    J Cardiovasc Med (Hagerstown); 2008 Dec; 9(12):1235-40. PubMed ID: 19001930
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The expanded Global Registry of Acute Coronary Events: baseline characteristics, management practices, and hospital outcomes of patients with acute coronary syndromes.
    Goodman SG; Huang W; Yan AT; Budaj A; Kennelly BM; Gore JM; Fox KA; Goldberg RJ; Anderson FA;
    Am Heart J; 2009 Aug; 158(2):193-201.e1-5. PubMed ID: 19619694
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The efficacy and safety of prasugrel with and without a glycoprotein IIb/IIIa inhibitor in patients with acute coronary syndromes undergoing percutaneous intervention: a TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis In Myocardial Infarction 38) analysis.
    O'Donoghue M; Antman EM; Braunwald E; Murphy SA; Steg PG; Finkelstein A; Penny WF; Fridrich V; McCabe CH; Sabatine MS; Wiviott SD
    J Am Coll Cardiol; 2009 Aug; 54(8):678-85. PubMed ID: 19679245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimal medical therapy with or without percutaneous coronary intervention in older patients with stable coronary disease: a pre-specified subset analysis of the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation) trial.
    Teo KK; Sedlis SP; Boden WE; O'Rourke RA; Maron DJ; Hartigan PM; Dada M; Gupta V; Spertus JA; Kostuk WJ; Berman DS; Shaw LJ; Chaitman BR; Mancini GB; Weintraub WS;
    J Am Coll Cardiol; 2009 Sep; 54(14):1303-8. PubMed ID: 19778673
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipid-rich plaque and myocardial perfusion after successful stenting in patients with non-ST-segment elevation acute coronary syndrome: an optical coherence tomography study.
    Tanaka A; Imanishi T; Kitabata H; Kubo T; Takarada S; Tanimoto T; Kuroi A; Tsujioka H; Ikejima H; Komukai K; Kataiwa H; Okouchi K; Kashiwaghi M; Ishibashi K; Matsumoto H; Takemoto K; Nakamura N; Hirata K; Mizukoshi M; Akasaka T
    Eur Heart J; 2009 Jun; 30(11):1348-55. PubMed ID: 19383736
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contribution of angiographic and electrocardiographic parameters of reperfusion to prediction of mortality and morbidity after acute ST-elevation myocardial infarction: Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction trial.
    Brener SJ; Westerhout CM; Fu Y; Todaro TG; Moliterno DJ; Wagner GS; Granger CB; Armstrong PW;
    Am Heart J; 2009 Nov; 158(5):755-60. PubMed ID: 19853693
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors and implications of Q-waves in ST-elevation acute coronary syndromes.
    LaBounty T; Gurm HS; Goodman SG; Montalescot G; Lopez-Sendon J; Quill A; Eagle KA;
    Am J Med; 2009 Feb; 122(2):144-51. PubMed ID: 19185091
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of usefulness of simvastatin 20 mg versus 80 mg in preventing contrast-induced nephropathy in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    Xinwei J; Xianghua F; Jing Z; Xinshun G; Ling X; Weize F; Guozhen H; Yunfa J; Weili W; Shiqiang L
    Am J Cardiol; 2009 Aug; 104(4):519-24. PubMed ID: 19660605
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Invasive versus conservative strategy in non-sT elevation acute coronary syndromes: data from a single Portuguese center.
    Teixeira R; Lourenço C; Baptista R; Jorge E; António N; Monteiro S; Gonçalves F; Monteiro P; Freitas M; Providência LA
    Rev Port Cardiol; 2009 Apr; 28(4):355-73. PubMed ID: 19634494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prehospital Delay in Patients With Acute Coronary Syndromes (from the Global Registry of Acute Coronary Events [GRACE]).
    Goldberg RJ; Spencer FA; Fox KA; Brieger D; Steg PG; Gurfinkel E; Dedrick R; Gore JM
    Am J Cardiol; 2009 Mar; 103(5):598-603. PubMed ID: 19231319
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Epidemiology of acute coronary syndrome in the City of Zagreb].
    Heim I; Jonke V; Gostović M; Jembrek-Gostović M
    Acta Med Croatica; 2009 Feb; 63(1):105-9. PubMed ID: 19681474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A first-in-man study of the Reitan catheter pump for circulatory support in patients undergoing high-risk percutaneous coronary intervention.
    Smith EJ; Reitan O; Keeble T; Dixon K; Rothman MT
    Catheter Cardiovasc Interv; 2009 Jun; 73(7):859-65. PubMed ID: 19455649
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Elective percutaneous coronary intervention after acute coronary syndrome].
    Sebetić D; Raguz M; Sakić I; Lazić J; Puksić S; Bergovec M
    Acta Med Croatica; 2009 Feb; 63(1):63-5. PubMed ID: 19681465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.